Test Price
2,800 AEDโ Home Collection Available
ZNF469 Gene Brittle Cornea Syndrome Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- โAccuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Next Generation Sequencing.
- โPremium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM โ 11 PM).
- โClinical Guidance: Telephonic post-test interpretation with a board-certified medical geneticist.
- โInsurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS-based genetic test provides comprehensive analysis of the ZNF469 gene coding regions and splice sites. It detects pathogenic variants associated with Brittle Cornea Syndrome, a rare autosomal recessive connective tissue disorder characterized by extreme corneal thinning, keratoglobus, and high risk of spontaneous corneal rupture. The test serves as the definitive diagnostic tool for ophthalmologists, clinical geneticists, and families at risk.
| Parameter | Our Test (NGS) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | Full gene coverage, including deep intronic & splice-site variants | Limited to targeted exons, may miss novel variants |
| Method | Massively parallel sequencing with 100ร mean depth | Bidirectional Sanger sequencing, lower analytical sensitivity |
| Speed | 3โ4 Weeks from sample receipt | 4โ6 Weeks typical |
Physician Insight & Safety Protocols
โAs a consultant medical geneticist, I recommend this NGS-based ZNF469 analysis for any patient with unexplained thin corneas, family history of corneal rupture, or clinical suspicion of a connective tissue disorder. A positive finding confirms the diagnosis, but phenotypic correlation with central corneal thickness, refractive error, and systemic features is essential. This test empowers families with precise risk information and guides proactive monitoring. Always interpret results in conjunction with a qualified genetic counselor or treating specialist.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Safety & Risk Advisory
Important Notice
This genetic test is not intended for emergency diagnosis of acute corneal perforation. If you experience sudden severe eye pain, acute vision loss, or visible corneal bulge, seek immediate ophthalmology emergency care. Do not discontinue prescribed eye drops or medications without consulting your physician. The test is purely diagnostic and should not replace ongoing clinical management.
Exclusion Criteria
- Not suitable as an emergency tool for acute corneal perforation; requires stable clinical condition.
- Minors: Parental or guardian consent and pre-test genetic counseling are mandatory.
- Prenatal testing: Not intended as a standalone prenatal diagnostic; confirmatory invasive testing (e.g., amniocentesis) required.
- Home collection: VIP Mobile Phlebotomy is available for standard whole blood or buccal swab specimens. No home collection for invasive samples.
Patient FAQ & Clinical Guidance
1. What is the ZNF469 genetic test and who should consider it?
Snippet: The ZNF469 NGS test analyzes the gene responsible for Brittle Cornea Syndrome, indicated for individuals with thin corneas, family history of corneal rupture, or suspected EhlersโDanlos syndrome.
This test detects mutations in the ZNF469 gene that cause Brittle Cornea Syndrome, a condition characterized by extreme corneal thinning and risk of spontaneous rupture. It is ideal for patients with clinical signs, family members of affected individuals, or those undergoing genetic counselling for connective tissue disorders.
2. How is the sample collected and what is the turnaround time?
Snippet: A simple blood draw or buccal swab is collected at home by a DHA-licensed phlebotomist, with results available in 3 to 4 weeks.
We offer flexible sample options: whole blood in EDTA, extracted DNA, or buccal swab. Our VIP home collection service operates from 8 AM to 11 PM daily, ensuring sample integrity with ISO-certified cold-chain transport. The entire process from sampling to clinical report takes 3โ4 weeks.
3. Will my insurance cover the cost of 2800 AED?
Snippet: We provide direct billing verification via WhatsApp; many UAE insurers cover genetic testing for confirmed clinical suspicion or family history.
Insurance coverage varies by provider. Our dedicated team will verify your policy in advance at no extra charge. Simply send a copy of your Emirates ID and insurance card to +971 54 548 8731, and we will confirm your eligibility and any required preโapprovals within one business hour.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
Your genetic data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing adheres to the safety and consent requirements stipulated in Federal Decree-Law No. 4 of 2016 on Medical Liability. Results are encrypted, shared only with your consent, and stored in UAE-based secure servers.
Clinical & Logistical Metadata
| Test Name | ZNF469 Gene (Brittle Cornea Syndrome) Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Buccal Swab |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Q78.8 |
| LOINC Code | 98544-9 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians